Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease

Journal of Lipid Research

Volumn 48, Issue 12, 2007, Pages 2640-2646

  Van Leuven, Sander I ^a   Hezemans, Rachelø ^a   Levels, Johannes H ^a   Snoek, Susan ^a   Stokkers, Pieter C ^a   Hovingh, G Kees ^a   Kastelein, John J P ^a   Stroes, Erik S ^a   De Groot, Eric ^a   Hommes, Daan W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Endothelium; Inflammation

Indexed keywords

ACUTE PHASE PROTEIN; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENTERITIS; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCORING SYSTEM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THROMBOSIS;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CROHN DISEASE; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; TUNICA INTIMA; TUNICA MEDIA;

EID: 37249046908     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700176-JLR200     Document Type: Article

References (55)

1. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420: 868-874.
2. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126.
3. van Leuven, S. I., J. J. Kastelein, M. R. Hayden, D. d'Cruz, G. R. Hughes, and E. S. Stroes. 2005. Cardiovascular disease in systemic lupus erythematosus: has the time for action come? Curr. Opin. Lipidol. 16: 501-506.
4. Sattar, N., D. W. McCarey, H. Capell, and I. B. McInness. 2003. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 108: 2957-2963.
5. van Leuven, S. I., R. R. Sankatsing, J. N. Vermeulen, J. J. Kastelein, P. Reiss, and E. S. Stroes. 2007. Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart! Curr. Opin. HIV AIDS. 2: 324-331.
6. Pussinen, P. J., K. Nyyssonen, and G. Alfthan. 2005. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 25: 833-838.
7. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196.
8. Navab, M., G. M. Anantharamaiah, and A. M. Fogelman. 2005. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15: 158-161.
9. de Groot, E., S. I. van Leuven, A. de Graaf, M. L. Bots, and J. J. P. Kastelein. 2007. Ultrasound measurements of carotid arterial walls and the progression and regression of atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. In press.
10. O'Leary, D. H., J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson, Jr. 1999. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 340: 14-22.
11. Levels, J. H., B. Bleijlevens, F. Rezaee, J. M. Aerts, and J. C. Meijers. 2007. SELDI-TOF mass spectrometry of high-density lipoprotein. Proteome Sci. 5: 15.
12. Navab, M., S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman. 2001. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42: 1308-1317.
13. Bargen, J. A., and N. W. Barker. 1936. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch. Intern. Med. 58: 17-31.
14. Silverstein, A., and D. H. Present. 1971. Cerebrovascular occlusions in relatively young patients with regional enteritis. J. Am. Med. Assoc. 215: 976-977.
15. Schneiderman, J. H., J. A. Sharpe, and D. M. Sutton. 1979. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann. Neurol. 5: 331-337.
16. Talbot, R. W., J. Heppell, R. R. Dozois, and R. W. Beart, Jr. 1986. Vascular complications of inflammatory bowel disease. Mayo Clin. Proc. 61: 140-145.
17. Prior, A., F. A. Strang, and P. J. Whorwell. 1987. Internal carotid artery occlusion in association with Crohn's disease. Dig. Dis. Sci. 32: 1047-1050.
18. Halliday, C. E., and M. J. Farthing. 1988. Arterial thrombosis in Crohn's disease. Med. J. Aust. 149: 559-560.
19. Novotny, D. A., R. J. Rubin, F. A. Slezak, and J. A. Porter. 1992. Arterial thromboembolic complications of inflammatory bowel disease. Dis. Colon Rectum. 35: 193-196.
20. Hahn, T. L., M. C. Dalsing, A. P. Sawchuk, D. F. Cikrit, and S. G. Lalka. 1999. Primary aortic mural thrombus: presentation and treatment. Ann. Vasc. Surg. 13: 52-59.
21. Novacek, G., M. Haumer, W. Schima, C. Muller, W. Miehsler, P. Polterauer, and H. Vogelsang. 2004. Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. Inflamm. Bowel Dis. 10: 430-435.
22. Danese, S., S. Semeraro, A. Papa, I. Roberto, F. Scaldaferri, G. Fedeli, G. Gasbarrini, and A. Gasbarrini. 2005. Extraintestinal manifestations in inflammatory bowel disease. World J. Gastroenterol. 11: 7227-7236.
23. Cattaneo, M., M. Vecchi, M. L. Zighetti, S. Saibeni, I. Martinelli, P. Omodei, P. M. Mannucci, and R. de Franchis. 1998. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb. Haemost. 80: 542-545.
24. Vianna, J. L., D. P. D'Cruz, M. A. Khamashta, R. A. Asherson, and G. R. Hughes. 1992. Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin. Exp. Rheumatol. 10: 165-168.
25. Vrij, A. A., J. Rijken, J. W. van Wersch, and R. W. Stockbrugger. 2003. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis. Pathophysiol. Haemost. Thromb. 33: 75-83.
26. Danese, S., and C. Fiocchi. 2003. Atherosclerosis and inflammatory bowel disease: sharing a common pathogenic pathway? Circulation. 107: e52.
27. Danese, S., L. Motte Cd Cde, and C. Fiocchi. 2004. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am. J. Gastroenterol. 99: 938-945.
28. Huo, Y., A. Schober, S. B. Forlow, D. F. Smith, M. C. Hyman, S. Jung, D. R. Littman, C. Weber, and K. Ley. 2003. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med. 9: 61-67.
29. van Leuven, S. I., J. J. Kastelein, D. P. D'Cruz, G. R. Hughes, and E. S. Stroes. 2006. Atherogenesis in rheumatology. Lupus. 15: 117-121.
30. van Leuven, S. I., R. Franssen, J. J. Kastelein, M. Levi, E. S. Stroes, and P. P. Tak. 2007. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology. In press.
31. Levy, P. J., A. H. Tabares, and J. W. Olin. 1997. Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. Am. J. Gastroenterol. 92: 494-497.
32. Younes-Mhenni, S., L. Derex, M. Berruyer, N. Nighoghossian, F. Philippeau, M. Salzmann, and P. Trouillas. 2004. Large-artery stroke in a young patient withCrohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. J. Neurol. Sci. 221: 113-115.
33. Nuutinen, H., M. Reunanen, M. Farkkila, and K. Seppala. 1995. Association of ulcerative colitis and ischemic heart disease (Abstract). Gastroenterology. 108: A886.
34. Nuutinen, H., M. Reunanen, M. Farkkila, and K. Seppala. 1996. Association of Crohn's disease and ischemic heart disease (Abstract). Gastroenterology. 110: A981.
35. Mutlu, B., C. M. Ermeydan, F. Enc, H. Fotbolcu, O. Demirkol, F. Bayrak, and Y. Basaran. 2002. Acute myocardial infarction in a young woman with severe ulcerative colitis. Int. J. Cardiol. 83: 183-185.
36. Papa, A., A. Santoliquido, S. Danese, M. Covino, C. Di Campli, R. Urgesi, A. Grillo, S. Guglielmo, P. Tondi, L. Guidi, et al. 2005. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 22: 839-846.
37. Papa, A., S. Danese, R. Urgesi, A. Grillo, S. Guglielmo, I. Roberto, M. Bonizzi, L. Guidi, I. De Vitis, A. Santoliquido, et al. 2006. Early atherosclerosis in patients with inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 7-11.
38. Schinzari, F., A. Armuzzi, B. De Pascalis, N. Mores, M. Tesauro, D. Melina, and C. Cardillo. 2007. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin. Pharmacol. Ther. In press.
39. Loftus, E. V., Jr. 2006. Crohn's disease: why the disparity in mortality? Gut. 55: 447-449.
40. Wolters, F. L., M. G. Russel, J. Sijbrandij, L. J. Schouten, S. Odes, L. Riis, P. Munkholm, P. Bodini, C. O'Morain, I. A. Mouzas, et al. European Collaborative Study Group on Inflammatory Bowel Disease. 2006. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut. 55: 510-518.
41. Kannel, W. B. 1983. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am. J. Cardiol. 52: 9B-12B.
42. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714.
43. Barter, P. J., S. Nicholls, K. A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman. 2004. Antiinflammatory properties of HDL. Circ. Res. 95: 764-772.
44. Aghdassi, E., B. E. Wendland, A. H. Steinhart, S. L. Wolman, K. Jeejeebhoy, and J. P. Allard. 2003. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am. J. Gastroenterol. 98: 348-353.
45. Navab, M., G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, and A. M. Fogelman. 2006. Mechanisms of disease: proatherogenic HDL - an evolving field. Nat. Clin. Pract. Endocrinol. Metab. 2: 504-511.
46. McMahon, M., J. Grossman, J. FitzGerald, E. Dahlin-Lee, D. J. Wallace, B. Y. Thong, H. Badsha, K. Kalunian, C. Charles, M. Navab, et al. 2006. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 54: 2541-2549.
47. Navab, M., J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L. W. Castellani, S. T. Reddy, D. Shih, W. Shi, A. D. Watson, et al. 2001. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21: 481-488.
48. Rezaee, F., B. Casetta, J. H. Levels, D. Speijer, and J. C. Meijers. 2006. Proteomic analysis of high-density lipoprotein. Proteomics. 6: 721-730.
49. Vaisar, T., S. Pennathur, P. S. Green, S. A. Gharib, A. N. Hoofnagle, M. C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, et al. 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117: 746-756.
50. Le, L., K. Chi, S. Tyldesley, S. Flibotte, D. L. Diamond, M. A. Kuzyk, and M. D. Sadar. 2005. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin. Chem. 51: 695-707.
51. Tolson, J., R. Bogumil, E. Brunst, H. Beck, R. Elsner, A. Humeny, H. Kratzin, M. Deeg, M. Kuczyk, G. A. Mueller, et al. 2004. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab. Invest. 84: 845-856.
52. Pruzanski, W., E. Stefanski, F. C. de Beer, M. C. de Beer, A. Ravandi, and A. Kuksis. 2000. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res. 41: 1035-1047.
53. Han, C. Y., T. Chiba, J. S. Campbell, N. Fausto, M. Chaisson, G. Orasanu, J. Plutzky, and A. Chait. 2006. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26: 1806-1813.
54. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.
55. Steinmetz, A., G. Hocke, R. Saile, P. Puchois, and J. C. Fruchart. 1989. Influence of serum amyloid-A on cholesterol esterification in human plasma. Biochim. Biophys. Acta. 1006: 173-178.